Sönmezer et al., 2013 |
19-35 |
Prospective randomized study |
Simple
randomization |
hemostatic matrix(=13) vs BE(=15) |
1 , 3 months |
single ovarian endometrioma ≥ 4 cm |
AMH |
Tanprasertkul et al., 2014 |
18-45 |
randomized controlled trial |
Simple randomization |
suture(=25) vs BE(=25) |
7 day, 1, 3, 6months |
unilateral or bilateral endometrioma |
AMH |
Song et al., 2014 |
18-45 |
randomized controlled trial |
Block
randomization |
hemostatic sealant (FloSealTM)(=49) vs BE(=49) |
3 month |
unilateral or bilateral ovrian cyst, 3-10 cm |
AMH decline
rate |
Zhang et al., 2016 |
18-45 |
randomized controlled trial |
Simple
randomization |
suture(=69) vs BE(=69) |
1, 3, 6, 12 month |
unilateral
or bilateral endometrioma |
FSH, AMH, AFC |
Asgari et al., 2016 |
18–42 |
randomized controlled trial |
Block
randomization |
suture(=52) vs BE(=57) |
3 month |
unilateral
endometriotic cysts |
AMH, FSH |
Sahin et al., 2017 |
18–40 |
randomized controlled trial |
Simple
randomization |
suture(=45) vs BE(=45) |
1, 3, 12 month |
unilateral
ovarian cyst |
AMH, AFC |
Choi et al., 2018 |
19–45 |
randomized controlled trial |
Simple
randomization |
hemostatic sealant ( FloSeal or TachoSil)(=40) vs
BE(=40) |
3 months |
unilateral or bilateral endometriomas 3–10 cm |
AMH |
Owczarek et al., 2018 |
20-35 |
randomized controlled trial |
Simple
randomization |
suture(=33) vs BE(=33) |
3 months |
ovary cyst 40-70 mm |
AMH, AFC |
Shaltout et al., 2019 |
20-35 |
randomized controlled trial |
Simple
randomization |
Surgicel(=50) vs BE(=50) |
6 months |
ovarian
endometriomas |
AMH, AFC |
Xiao et al., 2019 |
21-36 |
randomized controlled trial |
Simple
randomization |
suture(=40) vs BE(=40) |
1, 6 months |
bilateral ovarian cysts,
5-8 cm
|
AMH,
AFC, FSH |
Park et al., 2021 |
|
randomized controlled trial |
Simple randomization |
hemostatic sealant(=26) vs BE(=26) |
3 months |
unilateral ovarian
cyst |
AMH, AMH decline |
Chung et al., 2021 |
18-40 |
randomized controlled trial |
Simple
randomization |
FloSeal(=39) vs BE(=36) |
1, 3, 12 months |
unilateral
or bilateral endometriomas, 3-8 cm |
AMH, AFC, FSH |
Araujo et al., 2022 |
18-menopaused |
open-label, randomized controlled
trial |
Simple randomization |
suture+Surgicel(=50) vs BE(=27) |
1, 6
months |
unilateral endometrioma |
AMH |